🇺🇸 FDA
Patent

US 11648304

Zika vaccines and immunogenic compositions, and methods of using the same

granted A61KA61K2039/5252A61K2039/54

Quick answer

US patent 11648304 (Zika vaccines and immunogenic compositions, and methods of using the same) held by Takeda Vaccines, Inc. expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/5252, A61K2039/54, A61K2039/545, A61K2039/55505